This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.
CLSI POCT14
Original price was: $180.00.$90.00Current price is: $90.00.
Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline, POCT14AE
Clinical and Laboratory Standards Institute , 07/27/2020
Related products
-
CLSI C03-A4
Original price was: $110.00.$55.00Current price is: $55.00. -
CLSI I16T
Original price was: $178.00.$89.00Current price is: $89.00. -
CLSI GP41-A6
Original price was: $180.00.$90.00Current price is: $90.00. -
CLSI I03A
Original price was: $180.00.$90.00Current price is: $90.00. -
CLSI EP13R
Original price was: $202.00.$101.00Current price is: $101.00.